Journal article
Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review and meta-analysis of randomized clinical trials
Abstract
OBJECTIVES: Spasticity remains highly prevalent in patients with spinal cord injury and multiple sclerosis. To summarize the effects of cannabinoids compared with usual care, placebo for spasticity due to multiple sclerosis (MS) or paraplegia.
METHODS: Searches of MEDLINE, EMBASE, CENTRAL and LILACS to March 2017 were performed to identify randomized controlled trials. The primary outcomes were spasticity and spasm frequency. The criteria were …
Authors
da Rovare VP; Magalhães GPA; Jardini GDA; Beraldo ML; Gameiro MO; Agarwal A; Luvizutto GJ; Paula-Ramos L; Camargo SEA; de Oliveira LD
Journal
Complementary Therapies in Medicine, Vol. 34, , pp. 170–185
Publisher
Elsevier
Publication Date
October 2017
DOI
10.1016/j.ctim.2017.08.010
ISSN
0965-2299